Literature DB >> 24941373

Positive and negative regulation by NK cells in cancer.

Can M Sungur1, William J Murphy2.   

Abstract

Our understanding of NK biology has expanded immensely since the initial discovery of natural killer cells in 1975. New studies have uncovered various levels of immune regulation both on and by unique subsets of NK cells, which go well beyond simple receptor-ligand interactions between NK cells and target cancer cells. Distinct suppressor and effector populations of NK cells have been delineated in both viral and tumor models. Interactions between NK cells and dendritic cells, T cells, and B cells also dramatically alter the overall immune response to cancer. To exploit the diverse functional abilities of NK cell subsets for cancer immunotherapies, it is important to understand NK cell biology and NK regulator mechanisms.

Entities:  

Mesh:

Year:  2014        PMID: 24941373      PMCID: PMC4242411          DOI: 10.1615/critrevoncog.2014010805

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  77 in total

1.  A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.

Authors:  Aruna Mani; Julie Roda; Donn Young; Michael A Caligiuri; Gini F Fleming; Peter Kaufman; Adam Brufsky; Susan Ottman; William E Carson; Charles L Shapiro
Journal:  Breast Cancer Res Treat       Date:  2008-12-03       Impact factor: 4.872

Review 2.  Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.

Authors:  Loredana Ruggeri; Antonella Mancusi; Emanuela Burchielli; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Curr Opin Oncol       Date:  2007-03       Impact factor: 3.645

3.  Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.

Authors:  William H D Hallett; Erik Ames; Maite Álvarez; Isabel Barao; Patricia A Taylor; Bruce R Blazar; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

4.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

5.  Human spontaneous killer cells selective for tumour-derived target cells.

Authors:  M Jondal; C Spine; S Targan
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

Review 6.  Interleukin-2 therapy of metastatic renal cell carcinoma: update of phase III trials.

Authors:  David F McDermott; Meredith M Regan; Michael B Atkins
Journal:  Clin Genitourin Cancer       Date:  2006-09       Impact factor: 2.872

7.  Human NK cells: SET to kill.

Authors:  Jeffrey W Leong; Todd A Fehniger
Journal:  Blood       Date:  2011-02-24       Impact factor: 22.113

8.  Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells.

Authors:  Tony Avril; Elodie Vauleon; Abderrahmane Hamlat; Stéphan Saikali; Amandine Etcheverry; Caroline Delmas; Sylma Diabira; Jean Mosser; Véronique Quillien
Journal:  Brain Pathol       Date:  2011-09-16       Impact factor: 6.508

9.  Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules.

Authors:  Rossana Tallerico; Matilde Todaro; Simone Di Franco; Cristina Maccalli; Cinzia Garofalo; Rosa Sottile; Camillo Palmieri; Luca Tirinato; Pradeepa N Pangigadde; Rosanna La Rocca; Ofer Mandelboim; Giorgio Stassi; Enzo Di Fabrizio; Giorgio Parmiani; Alessandro Moretta; Francesco Dieli; Klas Kärre; Ennio Carbone
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

10.  Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-12-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Crosstalk between angiogenesis and immune regulation in the tumor microenvironment.

Authors:  Hei Jung Kim; Young Rae Ji; You Mie Lee
Journal:  Arch Pharm Res       Date:  2022-06-27       Impact factor: 6.010

Review 2.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

Review 3.  Recent Progress in the Synergistic Combination of Nanoparticle-Mediated Hyperthermia and Immunotherapy for Treatment of Cancer.

Authors:  Zachary R Stephen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2020-11-25       Impact factor: 9.933

4.  Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.

Authors:  Chandan Verma; Viriya Kaewkangsadan; Jennifer M Eremin; Gerard P Cowley; Mohammad Ilyas; Mohamed A El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2015-06-04       Impact factor: 5.531

Review 5.  Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells.

Authors:  Kevin O McNerney; Spyridon A Karageorgos; Michael D Hogarty; Hamid Bassiri
Journal:  Front Immunol       Date:  2020-05-08       Impact factor: 7.561

6.  Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity.

Authors:  Margaret G Gall; Hui Emma Zhang; Quintin Lee; Christopher J Jolly; Geoffrey W McCaughan; Adam Cook; Ben Roediger; Mark D Gorrell
Journal:  Sci Rep       Date:  2019-05-13       Impact factor: 4.379

7.  Immunomodulatory role of histamine H4 receptor in breast cancer.

Authors:  Helena A Sterle; Melisa B Nicoud; Noelia A Massari; Mónica A Táquez Delgado; María V Herrero Ducloux; Graciela A Cremaschi; Vanina A Medina
Journal:  Br J Cancer       Date:  2018-07-10       Impact factor: 7.640

8.  Soy isoflavones and their metabolites modulate cytokine-induced natural killer cell function.

Authors:  Thomas A Mace; Michael B Ware; Samantha A King; Shannon Loftus; Matthew R Farren; Elizabeth McMichael; Steven Scoville; Connor Geraghty; Gregory Young; William E Carson; Steven K Clinton; Gregory B Lesinski
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

Review 9.  The role of natural killer cells in hepatocellular carcinoma development and treatment: A narrative review.

Authors:  Sarun Juengpanich; Liang Shi; Yasaman Iranmanesh; Jiang Chen; Zhenzhe Cheng; Aaron Kah-Jin Khoo; Long Pan; Yifan Wang; Xiujun Cai
Journal:  Transl Oncol       Date:  2019-06-06       Impact factor: 4.243

Review 10.  The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy.

Authors:  Galaxia M Rodriguez; Kristianne J C Galpin; Curtis W McCloskey; Barbara C Vanderhyden
Journal:  Cancers (Basel)       Date:  2018-07-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.